Results 151 to 160 of about 254,702 (346)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Effects of Chinese green tea and Oolong tea on blood pressure, plasma and liver lipids in spontaneously hypertensive rats and rats with fructose-induced hyperlipidemia.

, 1987
Kazuko Iwata, Takayo INAYAMA, Satomi MIWA, K Kawaguchi   +3 more
openalex   +2 more sources

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Sex differences in the association between serum α-Klotho levels and hyperlipidemia: a cross-sectional study from NHANES 2013–2016

Scientific Reports
This study assessed the association between serum α-Klotho levels and hyperlipidemia. The aim was to ascertain the potential of serum α-Klotho levels as a predictive biomarker for hyperlipidemia.
Yu Han, Chao Liu, Ying Nie, Xijuan Jiang, Na An, Yabin Qin, Yinghua Ma, Zhihua An, Yile Zhao   +8 more
doaj   +1 more source

Retrospective Evaluation of the Association of Impaired Fasting Glucose and Hyperlipidemia in Patients Applying to the Family Medicine Outpatient Clinic [PDF]

, 2022
Özlem Polat, Özlem HARMANKAYA, Sadık Sami HATİPOĞLU   +2 more
openalex   +1 more source

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1474-1478, April 2025.
Abstract Aims ZSF1 obese rats harbouring two mutant leptin receptor alleles (Leprcp and Leprfa) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal model in cardiometabolic research.
Petra Büttner, Antje Augstein, Mahmoud Abdellatif, André Lourenço, Adelino Leite‐Moreira, Inês Falcão‐Pires, Sarah Werner, Holger Thiele, Simon Sedej, Antje Schauer, Volker Adams   +10 more
wiley   +1 more source

Mutations in Japanese Subjects with Primary Hyperlipidemia<BR>&mdash; Results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996 &mdash;

, 2004
Takao Maruyama, Shizuya Yamashita, Yūji Matsuzawa, Hideaki Bujo, Kazuo Takahashi, Yasushi Saitō, Shun Ishibashi, Ken Ohashi, Futoshi Shionoiri, Takanari Gotoda, Nobuhiro Yamada, Toru Kita   +11 more
openalex   +2 more sources

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Resveratrol supplementation improves metabolic control in rats with induced hyperlipidemia and type 2 diabetes

, 2019
Aleksandar Rašković, Veljko Ćućuz, Ljilja Torović, Ana Tomás, Ljiljana Gojković‐Bukarica, Tatjana Ćebović, Boris Milijašević, Nebojša Stilinović, Jelena Cvejić   +8 more
openalex   +1 more source

A practical guide to managing hypertension, hyperlipidemia, and hyperglycemia in patients with chronic myeloid leukemia [PDF]

, 2022
Khalid Ahmed, Rasha Kaddoura, Mohamed A. Yassin   +2 more
openalex   +1 more source